Literature DB >> 12401127

Albumin synthesis in humans increases immediately following the administration of endotoxin.

Hans Barle1, Anna Januszkiewicz, Lars Hållström, Pia Essén, Margaret A McNurlan, Peter J Garlick, Jan Wernerman.   

Abstract

In order to investigate the immediate (i.e. within 3 h) response of albumin synthesis to the administration of endotoxin, as a model of a moderate and well controlled catabolic insult, two measurements employing L-[(2)H(5)]phenylalanine were performed in 16 volunteers. One group ( n =8) received an intravenous injection of endotoxin (4 ng/kg; lot EC-6) immediately after the first measurement of albumin synthesis, whereas the other group received saline. A second measurement was initiated 1 h later. In the endotoxin group, the fractional synthesis rate of albumin was 6.9+/-0.6%/day (mean+/-S.D.) in the first measurement. In the second measurement, a significant increase was observed (9.6+/-1.2%/day; P <0.001). The corresponding values in the control group were were 6.6+/-0.6%/day and 7.0+/-0.6%/day respectively (not significant compared with first measurement and P <0.001 compared with the second measurement in the endotoxin group). The absolute synthesis rates of albumin were 148+/-35 and 201+/-49 mg x kg(-1) x day(-1) before and after endotoxin ( P <0.01). In the control group, the corresponding values were 131+/-21 and 132+/-20 mg x kg(-1) x day(-1) (not significant compared with the first measurement and P <0.01 compared with the second measurement in the endotoxin group). In conclusion, these results indicate that albumin synthesis increases in the very early phase after a catabolic insult, as represented by the administration of endotoxin.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12401127     DOI: 10.1042/cs1030525

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  8 in total

Review 1.  Human albumin solution for patients with cirrhosis and acute on chronic liver failure: Beyond simple volume expansion.

Authors:  Christopher Valerio; Eleni Theocharidou; Andrew Davenport; Banwari Agarwal
Journal:  World J Hepatol       Date:  2016-03-08

2.  Dynamics of albumin synthetic response to intra-abdominal abscess in patients with gastrointestinal fistula.

Authors:  Bo Zhou; Jianan Ren; Gang Han; Yu Chen; Jiye A; Guosheng Gu; Jun Chen; Gefei Wang; Jieshou Li
Journal:  Surg Infect (Larchmt)       Date:  2014-01-24       Impact factor: 2.150

Review 3.  Human serum albumin homeostasis: a new look at the roles of synthesis, catabolism, renal and gastrointestinal excretion, and the clinical value of serum albumin measurements.

Authors:  David G Levitt; Michael D Levitt
Journal:  Int J Gen Med       Date:  2016-07-15

4.  Simultaneous assessment of the synthesis rate and transcapillary escape rate of albumin in inflammation and surgery.

Authors:  András Komáromi; Ulrika Estenberg; Folke Hammarqvist; Olav Rooyackers; Jan Wernerman; Åke Norberg
Journal:  Crit Care       Date:  2016-11-15       Impact factor: 9.097

5.  Repeated quantitative measurements of De Novo synthesis of albumin and fibrinogen.

Authors:  Gabriel Dumitrescu; Andras Komaromi; Olav Rooyackers; Maria Klaude; Christina Hebert; Jan Wernerman; Åke Norberg
Journal:  PLoS One       Date:  2017-03-28       Impact factor: 3.240

6.  Albumin mass balance and kinetics in liver transplantation.

Authors:  Mariam Amouzandeh; Greg Nowak; Anna Januszkiewicz; Jan Wernerman; Olav Rooyackers; Åke Norberg
Journal:  Crit Care       Date:  2018-06-07       Impact factor: 9.097

7.  Albumin and fibrinogen kinetics in sepsis: a prospective observational study.

Authors:  Keisuke Omiya; Hiroaki Sato; Tamaki Sato; Linda Wykes; Mengyin Hong; Roupen Hatzakorzian; Arnold S Kristof; Thomas Schricker
Journal:  Crit Care       Date:  2021-12-17       Impact factor: 9.097

8.  Effect of albumin administration on outcomes in hypoalbuminemic patients hospitalized with community-acquired pneumonia (ALBUCAP): a prospective, randomized, phase III clinical controlled trial-a trial protocol.

Authors:  Alexander Rombauts; Gabriela Abelenda-Alonso; Antonella Francesca Simonetti; Guillermo Verdejo; Yolanda Meije; Lucia Ortega; Mercedes Clemente; Jordi Niubó; Yolanda Ruiz; Carlota Gudiol; Cristian Tebé; Sebastian Videla; Jordi Carratalà
Journal:  Trials       Date:  2020-08-20       Impact factor: 2.279

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.